Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Numedii is a next-generation biopharmaceutical company focused on transforming drug discovery and development to improve patients' lives. They employ a proprietary R&D platform that integrates big data analytics, artificial intelligence (AI), and systems biology to identify new drug targets, discover biomarkers, and develop precision medicines. Numedii's approach aims to significantly shorten timelines and reduce costs in developing therapies for areas with high unmet medical needs.
Serves as the primary center for Numedii's research, development, data science operations, strategic partnerships, and corporate administration.
Strategically situated in Palo Alto, offering access to a vibrant ecosystem of technological and biomedical talent. The office space is designed to foster collaboration and innovation among its scientific and technical teams.
Numedii promotes a work culture centered on scientific excellence, innovation, data-driven decision-making, and collaboration. Employees are typically mission-driven, focusing on leveraging technology to address complex healthcare challenges.
The Palo Alto location places Numedii at the nexus of cutting-edge technology and life sciences, facilitating access to talent, investment, and partnerships essential for its AI-driven drug discovery model.
Numedii's core operations are based in its Palo Alto headquarters. Its global reach is primarily achieved through strategic collaborations with international pharmaceutical companies, academic research institutions, and data providers. The company's AI platform analyzes diverse global datasets to identify therapeutic opportunities with worldwide relevance.
250 Cambridge Avenue, Suite 201
Palo Alto
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NuMedii' leadership includes:
NuMedii has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major announced executive hires or departures at Numedii within the past 12 months. The company's leadership team appears to have maintained stability during this period.
Discover the tools NuMedii uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Numedii likely uses a standard corporate email format. A common pattern for companies of its type is the first initial followed by the last name.
finitiallast@numedii.com
Format
gdeshpande@numedii.com
Example
75%
Success rate
Business Wire • June 7, 2023
Numedii, Inc. and Orbit Discovery Ltd announced a strategic collaboration aimed at identifying novel peptide drug candidates for challenging G-Protein Coupled Receptors (GPCRs) and ion channel targets. This partnership will combine Orbit's proprietary peptide display platform with Numedii's advanced AI-driven drug discovery and development platform, NUMai®....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NuMedii, are just a search away.